Cardiovascular Drug Pricing: Less Innovation for More Access?
Publication
, Journal Article
O'Connor, CM
Published in: JACC Heart Fail
July 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
July 2018
Volume
6
Issue
7
Start / End Page
613 / 614
Location
United States
Related Subject Headings
- United States
- Humans
- Drug Development
- Drug Costs
- Commerce
- Cardiovascular Agents
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M. (2018). Cardiovascular Drug Pricing: Less Innovation for More Access? JACC Heart Fail, 6(7), 613–614. https://doi.org/10.1016/j.jchf.2018.05.016
O’Connor, Christopher M. “Cardiovascular Drug Pricing: Less Innovation for More Access?” JACC Heart Fail 6, no. 7 (July 2018): 613–14. https://doi.org/10.1016/j.jchf.2018.05.016.
O’Connor CM. Cardiovascular Drug Pricing: Less Innovation for More Access? JACC Heart Fail. 2018 Jul;6(7):613–4.
O’Connor, Christopher M. “Cardiovascular Drug Pricing: Less Innovation for More Access?” JACC Heart Fail, vol. 6, no. 7, July 2018, pp. 613–14. Pubmed, doi:10.1016/j.jchf.2018.05.016.
O’Connor CM. Cardiovascular Drug Pricing: Less Innovation for More Access? JACC Heart Fail. 2018 Jul;6(7):613–614.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
July 2018
Volume
6
Issue
7
Start / End Page
613 / 614
Location
United States
Related Subject Headings
- United States
- Humans
- Drug Development
- Drug Costs
- Commerce
- Cardiovascular Agents
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology